Last Updated on October 15, 2024 by The Health Master
Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world’s largest market for medicines, owing to manufacturing issues.
As per the Enforcement Report by the US Food and Drug Administration (USFDA), Zydus Lifesciences (formerly known as Cadila Healthcare) is recalling 1,116 boxes of Fulvestrant Injection, a drug that is used to treat breast cancer.
According to the USFDA, the company’s US-based unit is recalling the affected lot due to “Failed Impurities/Degradation Specifications,” reported PTI.
The affected lot has been manufactured in India and has been distributed in the US by New Jersey-based Zydus Pharmaceuticals (USA), the report stated.
Zydus initiated the Class II voluntary recall on July 15 of this year.
Similarly, Baltimore-based Lupin Pharmaceuticals, Inc. is recalling 7,872 bottles of Rifampin Capsules, a medication used to treat infections caused by bacteria.
The company, a unit of Mumbai-based Lupin Ltd., is recalling the affected lot due to “Current Good Manufacturing Practice (CGMP) deviations.”
The drug initiated a Class II recall on July 28 of this year.
As per USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Drug recall: Glenmark, Strides Pharma, Cipla recalled these drugs
Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs
Drug recall: Atorvastatin 40 mg tablets recalled due to this reason
Drug recall: Magnesium Citrate Oral Solution recalled due to this reason
Drug recall: Propofol Injectable Emulsion recalled due to this reason
Drug recall: Insulin Glargine Injection Pens recalled due to this reason
Pharmacy Council: Elections process to elect 6 members begins
Bulk drug park: Booster shot for Pharma companies
NPPA seeks pricing details of Sodium Chloride 0.45% injection
USFDA issues Form 483 with 11 observation to Biocon
QR code on APIs – Active Pharmaceutical Ingredients
USFDA issues Form 483 with 2 observation to Alembic
NPPA: Silver jubilee celebrations of NPPA
USFDA gives approval to Loperamide HCL and Simethicone Tablets
FDA sets timelines for various regulatory approvals: Maharashtra
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
